CRISPR gene editing has made its way into every corner of modern biology, but there’s one place CRISPR can’t easily reach: mitochondria. Researchers have been looking for other ways to precisely edit the mitochondrial genome and the past few years have brought some success. Read the article: https://lnkd.in/eMtQXMTc
Nature Portfolio
Book and Periodical Publishing
London, Greater London 298,095 followers
About us
Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC.
- Website
-
https://www.nature.com/nature-portfolio
External link for Nature Portfolio
- Industry
- Book and Periodical Publishing
- Company size
- 501-1,000 employees
- Headquarters
- London, Greater London
- Type
- Privately Held
- Specialties
- Publishing and Science Publishing
Locations
-
Primary
Get directions
The Macmillan Building
4 Crinan Street
London, Greater London N1 9XW, GB
Employees at Nature Portfolio
Updates
-
Nature Portfolio reposted this
AI is now widely used across university campuses. I examined what this means for universities — and students — in a feature for Nature Magazine. Tools such as ChatGPT can, within seconds, analyse information and generate polished essays — some of the exact skills that universities have conventionally taught. So is this the future of learning or the road to students’ intellectual demise?! https://lnkd.in/ePc3rwsJ > I learned that some universities are fully embracing AI and weaving it into all their teaching; and a few studies hint that AI-powered tools can help students learn, especially if they encourage active learning. > But the list of concerns is long, including that students are using AI so shortcut through assignments and tests. Some studies hint that offloading work to AI can stifle learning and critical thinking. > Many students and faculty want clearer policies and training from universities on how to best use AI in teaching and learning. And some academics are angry that universities are encouraging use of AI tools given their unknown cognitive impact and ethical and environmental concerns. Many thanks to the many specialists in technology and education who spoke to me about this fascinating issue.
-
Join us December 8–10 in Boston for Cracking the Code: Nucleic Acid Medicines Coming of Age, where we will be bringing together leaders from academia, biotech, and pharma to advance the next generation of RNA- and DNA-based therapeutics. Meet they keynote speakers: Arthur Krieg: The mind behind CpG DNA immunostimulatory oligonucleotides, Krieg now pushes the boundary with RNA/DNA hybrid agonists for cancer immune activation. Muthiah (Mano) Manoharan: A pioneer in RNA chemistry whose work on conjugates, chemical modifications, and delivery systems made RNAi drugs a reality. Anna Marie Pyle: Structural RNA expert whose insights into RNA folding and enzyme interactions help bridge the gap between molecular architecture and therapeutic design. Why attend? Network across academia, biotech startups and pharma. Explore breakthroughs in delivery, specificity, immunogenicity, structure-guided design, and translational hurdles. Register by Nov. 7 to secure your space: https://lnkd.in/er5ffdWP
-
People with atopic dermatitis, an inflammatory skin disease, are at greater risk of neuropsychiatric conditions. A Nature Outlook feature examines the research to find out what causes the mental health burden of the disease. Read the article: https://lnkd.in/eHbnNsJw
-
-
Glioblastoma — the deadliest form of brain cancer — alters the calvarial bone and its marrow components, pushing it toward producing more myeloid cells and contributing to an immunosuppressive environment, according to a paper in Nature Neuroscience. Read the research: https://lnkd.in/eygF3jwc
-
-
We're #hiring a new Associate or Senior Editor, Nature Communications (Photovoltaics) in Nanjing, Jiangsu. Apply today or share this post with your network.
-
A Review in Nature Medicine summarizes recent technical advancements in generative AI, outlines how new models might improve healthcare and discusses validation approaches, using lessons from recent successes and failures in the field. Read the Review: https://lnkd.in/eBhatKsA
-
-
We're #hiring a new Specialist - Royalties in Pune, Maharashtra. Apply today or share this post with your network.
-
Tests of large language models reveal that they can behave in deceptive and potentially harmful ways. Nature reports on what these results mean for the future of AI. Read the article: https://lnkd.in/evvvqkCE
-
-
A paper in Nature Communication reports on a new method to produce strong, biodegradable plastic from bamboo. The bioplastic resembles oil-based plastics in strength, shapeability, and thermal stability but can biodegrade in soil within 50 days. Read the article: https://lnkd.in/gudxYGS7
-